A fully likelihood-based approach to model survival data with crossing
  survival curves by Demarqui, Fabio N. & Mayrink, Vinicius D.
A fully likelihood-based approach to model survival
data with crossing survival curves
Fábio Nogueira Demarqui∗
Vinicius Diniz Mayrink†
Abstract
Proportional hazards (PH), proportional odds (PO) and accelerated failure time
(AFT) models have been widely used to deal with survival data in different fields of
knowledge. Despite their popularity, such models are not suitable to handle survival
data with crossing survival curves. Yang and Prentice (2005) proposed a semipara-
metric two-sample approach, denoted here as the YP model, allowing the analysis of
crossing survival curves and including the PH and PO configurations as particular
cases. In a general regression setting, the present work proposes a fully likelihood-
based approach to fit the YP model. The main idea is to model the baseline hazard
via the piecewise exponential (PE) distribution. The approach shares the flexibility of
the semiparametric models and the tractability of the parametric representations. An
extensive simulation study is developed to evaluate the performance of the proposed
model. In addition, we demonstrate how useful is the new method through the analysis
of survival times related to patients enrolled in a cancer clinical trial. The simulation
results indicate that our model performs well for moderate sample sizes in the general
regression setting. A superior performance is also observed with respect to the original
YP model designed for the two-sample scenario.
Keywords: Survival analysis, Yang and Prentice model, short-term and long-term haz-
ard ratios, piecewise exponential distribution.
1 Introduction
Proportional hazards (PH) models have played a central role in the analysis of survival data.
Such class of models provides a very flexible framework to model survival data. They further
allow an easy interpretation of the parameters from the practical point of view. The main
assumption of the PH models is the proportionality of the hazard ratios over time. When
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such assumption is not verified by the data, some alternatives such as the proportional odds
(PO) and the accelerated failure time (AFT) models can be used in the analysis. However,
none of them is suitable to accommodate survival data with crossing survival curves. This
type of problem is often related to studies involving treatment and control groups. The
survival function for one group may have a fast decay in contrast with a slow decay for the
other. The curves tend to intersect at some time point configuring an inversion in terms
of who is on the top/bottom position. Studying this alteration is relevant in many clinical
trials, where the identification of the crossing time indicates when the target treatment for
a disease can be considered effective.
Survival data with crossing survival curves may arise due to several reasons in practice.
For instance, Diao et al. (2013) indicates that this may occur in certain clinical trials related
to aggressive treatments such as surgery. Some adverse effects can be observed in an initial
stage, but beneficial results may appear in the long run. According to Breslow (1974),
another situation connected with crossing survival functions is when a treatment has an
early and quick effect and it becomes similar to or worse than the placebo treatment after
certain period.
Several approaches have been proposed in the literature to accommodate this crossing
feature in survival data. The most popular ones are based on time-varying regression co-
efficients; see, for example, the references Egge and Zahl (1999), Shyur et al. (1999) and
Putter et al. (2005). Alternatively, Yang and Prentice (2005) presented a semiparametric
two-sample model (hereafter denoted as YP model) for this type of problem. The feature
“two-sample” refers to the scenario where, for example, there is a treatment and a control
group that can be conveniently represented through a binary variable. The YP proposal is
an interesting option, since it includes the PH and PO representations as particular cases.
In their model, the baseline hazard function is left unspecified, in fact a counting process
is assumed leading to a survival step function. A pair of short-term and long-term hazard
ratio parameters is included to accommodate crossing survival curves. In addition, a pseudo
maximum likelihood approach is considered for the estimation procedure. Consistency and
asymptotic normality of the resulting estimators are demonstrated in the paper.
Yang and Prentice (2011) extended the estimation procedure in Yang and Prentice (2005)
to pointwise and simultaneous inference on the hazard ratio function itself. They further
proved the consistency and asymptotic normality of the estimates at a fixed time point.
Yang et al. (2012) proposed two omnibus tests to evaluate the adequacy of the YP model.
The first test is based on the martingale residuals and the second one examines the con-
trast between the non-parametric and model-based estimators of the survival function. Diao
et al. (2013) extended the two-sample YP model to a general regression setting with possibly
time-dependent covariates; the study developed an efficient likelihood-based estimation pro-
cedure. The authors also demonstrated the consistency, asymptotic normality and efficiency
of the resulting estimators. The YP model has also been extended by Tong et al. (2007)
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to accommodate current status survival data. Another extension is found in Zhang et al.
(2017) to fit case II interval-censored data.
The use of semiparametric methods for univariate survival data started with Cox (1972)
on the proportional hazards model. Breslow (1972) and Breslow (1974) are two initial
publications proposing the use of the piecewise exponential (PE) distribution to replace the
baseline hazard in a survival analysis. The grid configuration for a PE model is a central
topic in Kalbfleisch and Prentice (1973); they explore different interval sizes for regular
grids. According to the authors, the grid should be chosen independently of the data. Many
applications, related to clinical trials and involving the PE distibution, can be found in the
literature; some few examples are: leukemia (Breslow, 1974), gastric cancer (Gamerman,
1991), kidney infection (Sahu et al., 1997; Ibrahim et al., 2001), breast cancer (Sinha et al.,
1999), melanoma (Demarqui et al., 2014) and hospital mortality (Clark and Ryan, 2002).
Although parametric in a strict sense, the PE model has a strong nonparametric appeal.
The main reason is the fact that assumptions about the shape of the baseline hazard are not
required in this approach.
The main contribution of the present paper is to propose a novel fully likelihood-based
approach to handle right-censored survival data with crossing survival curves. This is done
by assuming the PE distribution to deal with the baseline hazard in the YP model. We
emphasize that using the semiparametric PE approach to extend the original YP model has
never been considered in the literature. Some important advantages of the methodology pro-
posed here are: (i) it has the tractability of parametric models; (ii) it provides a continuous
survival function being convenient for the detection of the intersection point of two survival
curves; (iii) it has the flexibility of a semiparametric model allowing different shapes for the
hazard function, in contrast with the limited counting process assumed in the YP model
and their extensions; (iv) the routine for maximum likelihood estimation and inference is
straightforward and easy-to-implement. Another point to be highlighted is the fact that the
original reference for the YP model is focused on the two-sample case leaving the general
regression setting for future work. We explore the PE model with categorical and continuous
covariates in this paper.
This work is organized as follows. The proposed model is described in Section 2. A
comprehensive Monte Carlo simulation study is conducted in Section 3 to evaluate the per-
formance of the models. Section 4 shows an empirical illustration where the new model
is applied to study the survival times of patients enrolled in a gastric cancer clinical trial.
Finally, Section 5 presents the main conclusions, final remarks and discuss future research.
2 Model formulation
Let T be a nonnegative random variable representing the time until the occurrence of an
event of interest. In order to accommodate survival data with crossing survival curves, Yang
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and Prentice (2005) proposed the following model
S(t|z) =
[
1 +
λ
θ
R0(t)
]−θ
, (1)
where z = (z1, · · · , zp) is a set of explanatory variables, λ = exp{zψ} and θ = exp{zφ}, ψ =
(ψ1, · · · , ψp) and φ = (φ1, · · · , φp) are vectors of regression coefficients without intercepts,
and R0(t) = F0(t)/S0(t) corresponds to the baseline odds.
The hazard function, associated with (1), can be expressed as
h(t|z) = λθ
λF0(t) + θS0(t)
h0(t), (2)
where F0(t) = 1− S0(t) and h0(t) = − ddt log (S0(t)).
The YP model has some interesting and attractive features. First, it is easy to see from
(1) and (2) that the PH and PO models arise as particular cases when ψ = φ and ψ = 0,
respectively. Another point is that a scenario with crossing survival curves can be obtained
when ψjφj < 0, for any pair of coefficients (ψj,φj) and j = 1, · · · , p. Finally, it follows from
(2) that
lim
t→0
h(t|z)
h(t|0) = λ and limt→∞
h(t|z)
h(t|0) = θ (3)
The quantities λ and θ can be interpreted as the short-term and long-term hazard ratios,
respectively. In addition, the elements ψ and φ can be regarded as the short-term and
long-term regression coefficients, respectively.
We now describe the main aspects related to the piecewise exponential distribution.
Consider a time grid ρ = {a1, ..., am−1} inducing the following set of intervals:
Ik =
{
(ak−1, ak], k = 1, ...,m− 1
(am−1,∞), k = m
, (4)
with a0 = 0. We shall assume that the baseline hazard function appearing in (2) is constant
in each interval induced by ρ, that is
h0(t|ξ, ρ) = ξk, (5)
for t ∈ Ik and k = 1, · · · ,m.
The choice of the time grid in ρ has a significant impact in terms of goodness-of-fit for the
target model. A time grid with a large number of intervals might provide unstable estimates
for the failure rates. On the other hand, time grids with few intervals might lead to poor
approximations to the true survival function. In practice, the time grid selection must seek
a balance in terms of how well the hazard and survival functions can be estimated. Several
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approaches have been proposed in the literature to address this issue. We shall assume here
that the time grid ρ is a known quantity composed by a subset of the observed failure times.
For a detailed discussion regarding the choice of ρ, we recommend reading Demarqui et al.
(2011) and references therein.
Following Demarqui et al. (2011), the baseline survival function S0(t|ξ, ρ) can be conve-
niently expressed as:
S(t|ξ, ρ) = exp
{
−
m∑
k=1
ξk(tk − ak−1)
}
, (6)
where
tk =

ak−1, if t < ak−1
t, if t ∈ Ik
ak, if t > ak,
for k = 1, ...,m.
Consider now a random sample of size n, all elements are independent, and denote
by Ti and Ci the failure and censoring times, respectively. Let zi be a 1 × p vector of
explanatory variables associated with the i-th element in the sample. Assume that the
censoring mechanism is non-informative. In addition, the failure times are right-censored
so that Yi = min{Ti, Ci} is the observable failure time. The term δi = I{Ti ≤ Ci}, for
i = 1, · · · , n, is the failure indicator function. The set of observed data is then denoted by
D = {(yi, δi, zi); i = 1, · · · , n}. Finally, let Θ = (ψ,φ, ξ) represent the set of parameters
to be estimated. Since the time grid ρ is regarded as a known quantity in this paper, its
notation will be suppressed here for simplicity.
The likelihood function can be expressed as follows:
L(Θ;D) =
n∏
i=1
[
λiθi
θiS0(yi|ξ) + λiF0(yi|ξ)h0(yi|ξ)
]δi [
1 +
λi
θi
R0(yi|ξ)
]−θi
, (7)
where F0(yi) = 1− S0(yi), λi = exp{ziψ} and θi = exp{ziφ}.
In order to obtain the maximum likelihood estimates (MLEs) for the parameters, de-
noted by Θˆ, we proceed to the direct maximization of the log-likelihood function l(Θ) =
logL (Θ;D) by using the quasi-Newton BFGS method available in standard statistical soft-
wares such as R (R Core Team, 2018) and SAS (www.sas.com). The BFGS has been widely
used in the literature to solve optimization problems; see (Fletcher, 2000) for details. Fi-
nally, the variance-covariance matrix of Θˆ can be approximated by inverting the observed
information matrix I (Θˆ) = −l′′(Θˆ), which is readily provided, if requested, when applying
the BFSG through the R general purpose optimization command optim.
In the next section we empirically investigate some asymptotic properties of the MLEs
through a simulation study. This is a comprehensive study based on synthetic data replicated
in a Monte Carlo (MC) scheme. The main idea is to explore different aspects of the proposed
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model and compare its results with those from the standard YP model.
3 Simulation study
In this section, we present a Monte Carlo simulation study to evaluate the performance of
the model introduced in the previous section. There are two main purposes in this analysis:
(i) compare the proposed model with the two-sample semiparametric model in Yang and
Prentice (2005) and (ii) evaluated the performance of the new model in the general regression
setting.
In order to generate the synthetic data sets, the Weibull baseline survival function
S0(t|α, γ) = exp {−γtα}, with α = 1.50 and γ = 0.05, is assumed to generate the fail-
ure times (ti’s). The censoring times (ci’s) are obtained from the U(0, τ), with τ chosen so
that the censoring rate is approximately 30% of the observed data. Recall that the final
time reported for each sample unit is given by yi = min{ti, ci}. We begin the simulation
study with the two-sample scenario. The MC schemes are configured with 1,000 data sets
and they explore three different sample sizes: n = 50, n = 100 and n = 200. In each case, a
single binary covariate is included assuming zi ∼ Bernoulli(0.5), for i = 1, · · · , n.
All models were implemented and fitted using the R programming language (R Core
Team, 2018). In terms of optimization, we emphasize that the BFGS method is applied
through the function optim available in R. The semiparametric YP model in Yang and
Prentice (2005) can be fitted through the R package YPmodel; see more details in Yang and
Prentice (2010), Yang and Prentice (2011) and Yang et al. (2012).
The survival function, defined in the semiparametric YP model, is a step function with
jumps on the observed failure times. In order to ensure a fair comparison between our PE
model and the original YP model, the endpoints of the intervals forming the grid in the PE
model are set to be the observed failure times. In other words, each interval contains exactly
1 observation. Naturally, other configurations including more than 1 time point per interval
can be applied and this is expected to improve results.
The relative bias reported in Table 1 is calculated according to the following formulation:
RB(κ) = 100 (κˆ− κtrue) / |κtrue|.
In this expression consider that: κ is a generic parameter, κˆ is the maximum likelihood
estimate and κtrue is the true value. The relative bias is basically the ratio between the
estimation error and the magnitude of the true value. Negative and positive results indicate
underestimation and overestimation, respectively. The fraction is multiplied by 100 to adjust
scale leading to a quantity indicating a percentage representing how big is the error with
respect to the magnitude of the true value. This quantity is commonly used in the survival
analysis literature.
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Table 1: Summary for the MC simulation study with 1,000 replications and a single binary
covariate. Notation: fitted model (Mod), parameter name (Par), true value (True), average
point estimate (Est.), average standard error (ASE), sample standard deviation of the esti-
mates (SSDE), relative bias (RB), average 95% confidence interval and coverage probabilities
(CP).
n=50
95% CI
Mod Par True Est. ASE SSDE RB(%) Lower Upper CP
PE ψ 1.0 0.907 0.858 0.870 -9.269 -0.773 2.588 0.940
φ -1.0 -0.651 3.363 1.788 34.872 -7.242 5.940 0.981
YP ψ 1.0 1.150 1.419 1.522 14.976 -1.631 3.931 0.863
φ -1.0 -0.729 1.068 1.147 27.118 -2.822 1.364 0.924
n=100
95% CI
Mod Par True Est. ASE SSDE RB(%) Lower Upper CP
PE ψ 1.0 0.955 0.595 0.606 -4.511 -0.212 2.122 0.947
φ -1.0 -0.935 0.387 0.384 6.513 -1.694 -0.176 0.969
YP ψ 1.0 1.138 2.042 1.098 13.787 -2.864 5.140 0.946
φ -1.0 -0.930 1.701 0.585 6.992 -4.265 2.405 0.993
n=200
95% CI
Mod Par True Est. ASE SSDE RB(%) Lower Upper CP
PE ψ 1.0 0.991 0.417 0.418 -0.944 0.173 1.808 0.949
φ -1.0 -0.966 0.258 0.265 3.434 -1.471 -0.461 0.956
YP ψ 1.0 1.039 3.007 0.590 3.939 -4.854 6.933 0.994
φ -1.0 -0.939 2.412 0.530 6.135 -5.666 3.789 0.995
Table 1 shows the results of the Monte Carlo simulation study. As can be seen, neither the
proposed model nor the YP model performed well when the sample size is small (n = 50). In
this case, both models show relative biases above ≈ 10% and coverage probabilities far from
the nominal level for all parameters. Now looking at the moderate sample sizes (n = 100
and n = 200) the results in Table 1 change in favour of the proposed PE model. It is evident
that the PE model has a superior performance with respect to the standard semiparametric
YP model. Although an improvement in terms of relative bias reduction can be observed
for both models under moderate sample sizes, the proposed model provides smaller relative
biases and indicates coverage probabilities closer to the nominal level of 95%.
Another important aspect exhibited in Table 1 is the similar results for the ASE and SSDE
related to the proposed PE model. The similarity between these quantities is expected in
a MC study, since the MC error for a parameter tend to reflect, on average, the estimator
standard error in each replicated data set. Note that this type of result is not true for the
standard semiparametric YP model, which seems to overestimate the standard errors of the
parameter estimators. In addition, this bad behavior can explain the wider average 95%
confidence interval limits and the coverage probabilities above the nominal level observed
for this model.
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We now turn our attention to the general regression setting. Moderate to large data sets
were considered in this analysis to investigate the performance of the proposed PE model
assuming a regression structure with four covariates. Synthetic data sets were simulated
taking into account three different sample sizes: n = 100, n = 200 and n = 500. We again
use the MC scheme with 1,000 replications. The following short-term and long-term linear
predictors are explored:
log(λi) = +2.0z1i − 0.5z2i + 1.5z3i − 1.5z4i
log(θi) = −1.0z1i + 1.0z2i − 1.5z3i + 1.5z4i
(8)
where z1i ∼ Bernoulli(0.5), z2i ∼ N(0, 1), z3i ∼ Bernoulli(0.5) and z4i ∼ N(0, 1), for i =
1, · · · , n.
The main reference Yang and Prentice (2005) is entirely focused on the two-sample
scenario and does not explore the general regression setting. In fact the paper indicates
that the standard YP model can be extended to incorporate covariates, but this was left for
future work in that opportunity. The corresponding R package YPmodel does not allow the
analysis using the general configuration. As a consequence of this point, in the next analysis
we do not confront the results from the PE model and the standard YP case. Recall that, for
comparison reasons, the time grid for the PE model was initially chosen (analysis of Table 1),
with 1 observation per interval. The results presented in Table 2 are obtained by assuming
a different grid structure. In this case, the number of intervals is given by m =
√
n. This
choice is convenient to reduce the computational burden to fit the model. The endpoints of
the intervals are chosen according to the ideas described in Demarqui et al. (2011).
As it can be seen from Table 2, relative biases are reasonably low, especially for n = 200
and n = 500. In addition, the coverage probabilities are, in general, close to the nominal
level of 95%. Another important aspect observed here is the fact that both bias and ASE
tend to decrease as the sample size increases. The results displayed in Table 2 also indicate
that the standard errors of the parameters are being well estimated, since the ASE and
SSDE have similar values for all parameters; this is true regardless of the sample size under
investigation. Overall, the proposed model seems to perform well in the general regression
setting for moderate to large data sets.
4 Real data application
This section is dedicated to the analysis of a real data set freely available through the R
package YPmodel under the label of gastric; see also Gastrointestinal Tumor Study Group
(1982) as a formal reference for more details. This gastric cancer data set has become a
common application in the literature related to survival analysis and, more specifically, it
can be easily found in studies dealing with crossing survival curves; some few references
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Table 2: Summary for the MC simulation study with 1,000 replications and 4 covariates.
Notation: parameter name (Par), true value (True), average point estimate (Est.), average
standard error (ASE), sample standard deviation of the estimates (SSDE), relative bias
(RB), average 95% confidence interval and coverage probabilities (CP).
n = 100 and m = 10
95% CI
Par True Est. ASE SSDE RB(%) Lower Upper CP
ψ1 2.0 1.903 0.614 0.656 -4.855 0.700 3.106 0.931
ψ2 -0.5 -0.473 0.296 0.315 5.314 -1.053 0.106 0.940
ψ3 1.5 1.415 0.615 0.655 -5.657 0.209 2.621 0.919
ψ4 -1.5 -1.477 0.402 0.416 1.562 -2.264 -0.689 0.942
φ1 -1.0 -0.913 0.347 0.397 8.664 -1.593 -0.234 0.927
φ2 1.0 1.047 0.238 0.258 4.738 0.581 1.514 0.951
φ3 -1.5 -1.459 0.350 0.372 2.718 -2.145 -0.773 0.952
φ4 1.5 1.547 0.266 0.295 3.156 1.026 2.068 0.964
n = 200 and m = 15
95% CI
Par True Est. ASE SSDE RB(%) Lower Upper CP
ψ1 2.0 1.946 0.422 0.412 -2.704 1.119 2.773 0.945
ψ2 -0.5 -0.479 0.200 0.209 4.181 -0.871 -0.087 0.937
ψ3 1.5 1.430 0.423 0.438 -4.692 0.600 2.259 0.933
ψ4 -1.5 -1.475 0.276 0.284 1.689 -2.015 -0.935 0.937
φ1 -1.0 -0.953 0.233 0.237 4.657 -1.411 -0.496 0.955
φ2 1.0 1.034 0.160 0.162 3.367 0.720 1.348 0.945
φ3 -1.5 -1.477 0.237 0.251 1.535 -1.941 -1.012 0.939
φ4 1.5 1.528 0.179 0.185 1.848 1.178 1.878 0.937
n = 500 and m = 23
95% CI
Par True Est. ASE SSDE RB(%) Lower Upper CP
ψ1 2.0 1.976 0.264 0.270 -1.223 1.458 2.493 0.936
ψ2 -0.5 -0.485 0.123 0.124 2.905 -0.727 -0.244 0.948
ψ3 1.5 1.463 0.264 0.261 -2.441 0.946 1.981 0.949
ψ4 -1.5 -1.472 0.171 0.174 1.866 -1.807 -1.137 0.936
φ1 -1.0 -0.978 0.144 0.143 2.177 -1.261 -0.695 0.958
φ2 1.0 1.010 0.098 0.097 1.035 0.818 1.202 0.953
φ3 -1.5 -1.482 0.146 0.142 1.218 -1.769 -1.195 0.955
φ4 1.5 1.518 0.110 0.115 1.227 1.303 1.734 0.931
are: Yang et al. (2012), Diao et al. (2013), Lee (2011) and Yang (2018). The experiment
in this clinical trial involves 90 individuals diagnosed with locally unresectable (advanced)
gastric cancer. The participants were randomly assigned to the following groups: (i) the
control group composed by 45 patients receiving chemotherapy and (ii) the treatment group
including 45 patients receiving a combination of chemotherapy and radiation therapy. These
individuals were followed within this study for about 5 years. Three variables are reported
in the data set for each patient: the time response representing either a failure (time to
death) or a right censoring, a binary failure indicator identifying those patients experiencing
the event of interest and, finally, a group binary indicator with 1 meaning the treatment
category. Note that this application contains a single binary covariate; therefore, it can be
explored and compared via the PE and YP standard models.
Table 3 summarizes the results obtained for both models. As it can be observed, the
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short-term (ψ) and long-term (φ) regression coefficients, within each model, are estimated
with opposite signs and they have distinct magnitudes. This can be observed by either
looking at the point estimate (column Est.) or the 95% confidence intervals. This behavior
is a clear indication of survival curves having an intersection at some intermediate time point
between 0 and the maximum. In other words, the top and bottom positioning of the curves
are inverted for the intervals below and above the crossing time point; see Figure 1 for a
visual idea. This inversion suggests the existence of an alteration in the effectiveness of the
treatment at some point during the follow up period of the study. In general, the results
tend to be similar when comparing the corresponding estimates from both models. Note
that the standard error related to ψ is larger then the one for φ. In addition, all p-values
from the z-test are small, indicating significant estimates.
Table 3: Summary of the models fitted to the gastric cancer data.
95% CI
Model Par Est. SE lower upper z p-value
PE ψ 1.837 0.648 0.567 3.108 2.834 0.005
φ -1.017 0.300 -1.606 -0.429 -3.387 0.001
YP ψ 1.600 0.538 0.547 2.656 2.977 0.003
φ -0.906 0.248 -1.393 -0.421 -3.650 0.000
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Figure 1: Analysis of the gastric cancer data set. Left panel: Kaplan-Meier estimates for
the survival curves along with the PE estimates (solid lines) and the YP estimates (dashed
lines). Right panel: estimated survival curves provided by the proposed model along with
the estimated time point at which the survival curves probably cross each other.
One interesting and attractive feature of the proposed PE model is the fact that it
provides a continuous survival function. This aspect allows us to apply standard procedures
to find the roots of nonlinear equations to determine accurately the time point at which the
survival curves intersect each other. One possibility to handle this problem in R is to use
the command uniroot (Brent, 1973) for unidimensional searches. In line with this idea,
right after fitting our PE model to the gastric cancer data, we apply the uniroot function
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to conclude that the crossing time occurs, for this application, at the time point given by
the day 863 within the full period of the study. From the practical point of view, this
means that before the day 863, the patients in the control group (only chemotherapy) have
better survival rates than those in the treatment group. On the other hand, the benefits
of combining chemotherapy with radiotherapy tend to emerge in a later stage of the study
(after day 863).
The left panel of Figure 1 shows: the Kaplan-Meier curves associated with the two
treatments and the survival curves estimated via the semiparametric PE and YP models.
The right side panel of Figure 1 displays the estimated survival curves, provided by the
proposed PE model, along with the estimated time at which the survival curves are expected
to cross. As can be seen in the left panel, both models seem to accommodate and represent
well the data, since their estimated survival curves tend to agree with the Kaplan-Meyer
survival estimates.
5 Conclusions
This paper presents a fully likelihood-based approach to deal with crossing survival curves as
an extension to the standard YP model proposed in 2005 for a two-sample case. The main
difference with respect to other extensions of the YP model is the fact that we take advantage
of the piecewise exponential semiparametric modeling to allow a flexible representation of
the baseline hazard function. This also configures the main contribution of the paper, since
no other study combining these two aspects (YP model structure and PE distribution)
can be found in the literature of survival analysis. Using the PE distribution brings some
advantages when comparing to other semiparametric options for the YP model. The PE
model preserves the flexibility of the semiparametric models and the tractability of the
parametric ones. In addition, it is relatively easy-to-implement using standard maximization
routines. Estimation of parameters, hazard function, survival function and hazard ratios is
straightforward. Another important aspect to be emphasized is the fact that the survival
function has a continuous representation via the PE model; this is not true in the original YP
model and other approaches presented in the literature, where a step function is obtained as
the survival representation. As a result of this feature, the time in which the survival curves
(treatment and control groups) intersect each other can be easily and accurately determined.
A comprehensive MC simulation study was developed to examine the performance of the
proposed PE model in comparison with the YP model. The results indicate that the PE
model provides better results with smaller relative biases being observed for most parameters.
Using synthetic data sets, the behavior of the PE model was also investigated for a general
regression setting involving several covariates. The standard YP model can be extended to
this context, but the original paper in 2005 does not explore this type of result. Our findings
suggest that the PE model also has a good performance when dealing with several covariates.
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The final analysis of the paper is focused on a real application related to a well known data
set related to a clinical trial for patients detected with advanced gastric cancer. In summary,
the results of the PE and YP model are similar and they clearly indicate significant regression
coefficients with opposite signs, which is expected for the scenario where the survival curves
have an intersection.
In terms o future work, we plan to develop an R package to fit the proposed PE model.
The approach presented here can also be extended to accommodate survival data with cure
fraction and interval-censored observations. This is beyond the scope of the current paper
and will be addressed in upcoming papers.
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